Prevalence of hepatitis C virus among street children in Iran

Masoud Behzadifar1, Hasan Abolghasem Gorji2, Aziz Rezapour3

  • 1Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Insights

Hepatitis C virus (HCV) infection is prevalent among street children in Iran, with a high rate of 2.4%. This highlights the urgent need for increased health support and targeted interventions for this vulnerable population.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Street children face significant health risks due to unstable living conditions and lack of access to healthcare.
  • Hepatitis C virus (HCV) infection is a growing concern among vulnerable populations globally.
  • The prevalence of HCV among street children in Iran remains largely undocumented, necessitating focused research.

Purpose of the Study:

  • To determine the prevalence of HCV infection among street children in Iran.
  • To synthesize existing data on HCV among this demographic through a systematic review and meta-analysis.

Main Methods:

  • Systematic review and meta-analysis adhering to PRISMA guidelines.
  • Comprehensive literature search across international and Iranian databases (1988-2017).
  • Inclusion of four studies (2006-2017) involving 1691 street children in Iran.

Main Results:

  • The overall prevalence of HCV among street children in Iran was found to be 2.4% (95% CI: 1.8-3.3).
  • Studies were concentrated in Tehran and Isfahan, indicating a need for broader geographical data.
  • The identified prevalence suggests a significant public health issue within this population.

Conclusions:

  • The high HCV prevalence necessitates increased attention from health policymakers and expanded social/economic support for street children.
  • Further research across diverse Iranian cities is crucial to comprehensively understand HCV epidemiology in this group.
  • The health system should facilitate screening and early diagnosis to prevent HCV complications in street children.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
What are Viruses?00:50

What are Viruses?

Overview
128.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
245
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
302